132 related articles for article (PubMed ID: 7585513)
1. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukas J; Aagaard L; Strauss M; Bartek J
Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
[TBL] [Abstract][Full Text] [Related]
2. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
3. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
6. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 as a cellular proto-oncogene.
Bates S; Peters G
Semin Cancer Biol; 1995 Apr; 6(2):73-82. PubMed ID: 7647309
[TBL] [Abstract][Full Text] [Related]
9. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression.
Del Sal G; Murphy M; Ruaro E; Lazarevic D; Levine AJ; Schneider C
Oncogene; 1996 Jan; 12(1):177-85. PubMed ID: 8552389
[TBL] [Abstract][Full Text] [Related]
11. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
Lukas J; Bartkova J; Welcker M; Petersen OW; Peters G; Strauss M; Bartek J
Oncogene; 1995 Jun; 10(11):2125-34. PubMed ID: 7784057
[TBL] [Abstract][Full Text] [Related]
13. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
Gjetting T; Lukas J; Bartek J; Strauss M
Biol Chem Hoppe Seyler; 1995 Jul; 376(7):441-6. PubMed ID: 7576242
[TBL] [Abstract][Full Text] [Related]
14. Happenstance, circumstance or enemy action: cyclin D1 in breast, eye and brain.
Schmidt EV
Bioessays; 1996 Jan; 18(1):6-8. PubMed ID: 8593165
[TBL] [Abstract][Full Text] [Related]
15. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
16. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
Marhin WW; Hei YJ; Chen S; Jiang Z; Gallie BL; Phillips RA; Penn LZ
Oncogene; 1996 Jan; 12(1):43-52. PubMed ID: 8552398
[TBL] [Abstract][Full Text] [Related]
17. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
20. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ
Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
